268 results
Page 4 of 14
8-K
EX-99.2
1mr7 5eek4u
25 Jul 13
Bristol-Myers Squibb Reports Second Quarter 2013 Financial Results
12:00am
8-K
EX-99.2
umhrbuv 6p7f
25 Apr 13
Bristol-Myers Squibb Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99.2
b6m2a0rkhn
24 Jan 13
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2012 Financial Results
12:00am
8-K
EX-99.2
ae58c7mioif0f61w
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
sww3qzyzgb1
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
huspq5nrc8bwszwb
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-99.2
f9yqgz3 in2
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-2.1
bgk2rzcl2ei 0uv3w6
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
CORRESP
ur5rthbzcghwd8m
17 May 12
Correspondence with SEC
12:00am
8-K
EX-99.2
vwby8
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am
8-K
EX-99.1
a3vum2ctfr849 pp
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am